Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
BioLargo, Inc. (OTCQX: BLGO) regularly issues news and updates about its cleantech, environmental, energy, and life sciences activities. As a developer of sustainable technologies and a full-service environmental engineering company, its announcements often focus on progress in PFAS water treatment, advanced wastewater solutions, odor and VOC control, air quality, energy storage, and medical infection control and wound care.
Recent news has highlighted BioLargo’s Aqueous Electrostatic Concentrator (AEC) platform, including reported breakthroughs that significantly reduced the system’s energy use in large-scale PFAS treatment and its deployment at a municipal drinking water facility in Lake Stockholm, New Jersey. Coverage also includes recognition of BioLargo Equipment Solutions & Technologies, Inc. in industry media for PFAS treatment advances and updates on commercial demonstration projects.
Investors and observers can also find announcements about BioLargo’s Cellinity battery technology for grid-scale energy storage, its role in broader infrastructure and clean energy discussions, and participation in conferences and investor events such as LD Micro and NobleCon. These items provide context on how the company positions its technologies within evolving infrastructure, data center, and energy investment cycles.
On the life sciences side, news items cover Clyra Medical Technologies’ progress in infection control and advanced wound care, including the ViaCLYR wound irrigation solution and its exclusive distribution alliance with Advanced Solution, LLC. Regulatory, legal, and corporate developments—such as SEC-reported events, financial updates, and intellectual property enforcement actions related to odor control technologies—are also common topics. This news page allows readers to follow BioLargo’s ongoing technical milestones, commercialization steps, and corporate disclosures in one place.
BioLargo, Inc. (OTCQB:BLGO) filed its Q1 2021 report, highlighting a 30% revenue increase to $571,000 compared to the previous year. The company's net loss decreased by 28% thanks to a significant reduction in interest expenses. BioLargo has retired $650,000 in debt this year, improving its financial position ahead of plans to uplist to a national exchange. CEO Dennis Calvert emphasized the commercial potential of their PFAS remediation technology in a growing $80 billion market. Upcoming commercial pilots for this technology are set to start soon.
BioLargo, Inc. (OTCQB:BLGO) will host an investor webcast and conference call on May 19, 2021, at 1:30 PM PT / 4:30 PM ET. The session aims to discuss the company's financial results and recent developments. The event is open to the public, with access to a replay available for later viewing. BioLargo specializes in developing sustainable technologies for environmental challenges, holding numerous patents, and operating through various subsidiaries. The webcast details and participation links are provided in the company’s investor relations section.
BioLargo, Inc. (OTCQB:BLGO) will present at the Benzinga Global Small Cap Conference on May 14, 2021, at 10:10 a.m. ET. The conference aims to connect small-cap companies with investors, focusing on cleantech advancements and growth prospects. CEO Dennis P. Calvert emphasizes BioLargo's dynamic business model, notably in PFAS remediation and water treatment. The event is free to attend, providing valuable insights into the company's innovative solutions. For registration, visit here.
BioLargo, Inc. (OTCQB:BLGO) has achieved a significant technical milestone with its Aqueous Electrostatic Concentrator (AEC), designed for treating PFAS-contaminated water. This development improves the AEC's electrical configuration, significantly reducing operating and maintenance costs. As a result, BioLargo can now finalize agreements for demonstration pilots and commercial trials. The AEC offers advantages over traditional PFAS filtration methods, with lower waste generation and reduced costs. The company is also enhancing its intellectual property related to the technology.
BioLargo, Inc. (OTCQB:BLGO) will present at the Benzinga Cleantech Small Cap Conference on April 22, 2021, at 11:20 AM EST. The company specializes in sustainable technologies and environmental engineering. CEO Dennis P. Calvert emphasized BioLargo's advancements in water remediation technologies, aimed at addressing critical global challenges. The conference focuses on clean technologies that promote eco-friendly practices.
Interested parties can sign up for the conference here.
BioLargo, Inc. (OTCQB:BLGO) filed its 2020 Annual Report with significant highlights. Revenue reached $2.43 million, a 31% increase from 2019, with fourth-quarter revenue of $900,000, up 36% from the previous quarter. The company reduced debt from $4.8 million to $1.7 million and announced the upcoming commercial launch of its PFAS water treatment solution. BioLargo continues to enhance its strategic partnerships and expand its technology offerings, positioning for future growth despite challenges from the COVID-19 pandemic.
BioLargo, Inc. (OTCQB:BLGO) announces a webcast and conference call on March 31, 2021, at 2 PM PST to discuss its 2020 financial results, releasing them after market close on March 30, 2021. The event will include a Q&A session open to the public. Interested participants can access the webcast on the company's Investor Relations page. BioLargo focuses on innovative environmental solutions and has secured over 80 grants to support its initiatives.
BioLargo, Inc. (OTCQB:BLGO) announced that CEO Dennis Calvert will present at the Q1 Virtual Investor Summit on March 25, 2021, at 1:30 PM ET. This event connects small- and mid-cap companies with investors. Calvert's presentation will showcase the company's sustainable technologies and their deployment across the country. BioLargo specializes in solving environmental challenges, holding numerous patents and grants. The summit features approximately 100 companies and aims to foster direct connections between companies and over 300 qualified investors.
BioLargo, Inc. (OTCQB:BLGO) has been invited to present its innovative AOS (Advanced Oxidation System) water treatment technology at Isle Utilities' iTAG event on March 4, 2021. Industry leaders from companies like Coca-Cola and Shell will participate in this event aimed at exploring sustainable water technologies. The AOS technology excels in efficient disinfection and removal of pharmaceutical micropollutants, making it valuable for various water treatment applications. This opportunity coincides with BioLargo's rollout of AOS through commercial trials at a poultry farm in Alberta, Canada.
BioLargo, Inc. (OTCQB:BLGO) announced it has eliminated $650,000 in debt, primarily due in August 2021. Remaining debts are manageable, with expectations for forgiveness on most SBA loans. This move aligns with reducing costly convertible debt and interest expenses. The company reported ongoing commercial milestones, including a new water treatment project expected to generate $500,000 in revenue and a $2 million project backlog. CEO Dennis P. Calvert emphasized their strong cash position and growth potential through innovative partnerships and technologies aimed at environmental challenges.